Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
X-Mark is a medical device company that specializes in the development and manufacturing of surgical site marking systems. The company's primary focus is on improving patient safety by providing clinical solutions that prevent wrong-site, wrong-procedure, and wrong-person surgeries. Their product portfolio includes specialized skin markers and labels designed to remain visible throughout the surgical preparation process. In 2015, X-Mark was acquired by Halyard Health (now Avanos Medical) to bolster its surgical and infection prevention business unit. Today, its technologies are integrated into broader surgical safety protocols across healthcare facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xmark.